Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2021 |
Jun. 30, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Revenue | $ 20,419 | $ 14,174 | $ 40,539 | $ 31,875 | $ 71,851 | $ 72,549 |
| Cost of revenue | 8,496 | 6,720 | 16,435 | 14,997 | 29,921 | 36,321 |
| Gross profit | 11,923 | 7,454 | 24,104 | 16,878 | 41,930 | 36,228 |
| Operating expense | ||||||
| Sales and marketing | 8,255 | 5,296 | 15,312 | 11,761 | 22,413 | 31,018 |
| Research and development | 6,444 | 4,206 | 11,703 | 8,852 | 17,176 | 20,270 |
| General and administrative | 7,959 | 3,623 | 16,822 | 7,250 | 20,080 | 15,683 |
| Total operating expense | 22,658 | 13,125 | 43,837 | 27,863 | 59,669 | 66,971 |
| Loss from operations | (10,735) | (5,671) | (19,733) | (10,985) | (17,739) | (30,743) |
| Other (expense) income, net | (345) | 10 | (1,368) | 23 | (184) | (121) |
| Interest expense | (5) | (20) | (9) | (29) | (98) | (49) |
| Interest income | 1 | 21 | 3 | 144 | 147 | 1,053 |
| Loss before income taxes | (11,084) | (5,660) | (21,107) | (10,847) | (17,874) | (29,860) |
| Income tax expense | 6 | 29 | 2 | 87 | 111 | 15 |
| Net loss and comprehensive loss | $ (11,090) | $ (5,689) | $ (21,109) | $ (10,934) | (17,985) | (29,875) |
| Net loss attributable to MarkForged, Inc. common stockholders | $ (18,811) | $ (31,284) | ||||
| Weighted average shares outstanding basic and diluted | 41,853,841 | 39,980,784 | 41,638,004 | 39,856,193 | 40,258,968 | 38,673,218 |
| Basic and diluted net loss per common share | $ (0.26) | $ (0.14) | $ (0.51) | $ (0.27) | $ (0.47) | $ (0.81) |
| Series Seed Redeemable Convertible Preferred Stock [Member] | ||||||
| Operating expense | ||||||
| Deemed dividend | $ 0 | $ (785) | ||||
| Common Stock [Member] | ||||||
| Operating expense | ||||||
| Deemed dividend | $ (826) | $ (624) | ||||
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends). No definition available.
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|